# A Phase I Clinical Trial of BAT1306 and BAT8001 Injection in Patients With Solid Tumor

> **NCT04151329** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Bio-Thera Solutions** · enrollment: 72 (estimated)

## Conditions studied

- Solid Tumor

## Interventions

- **BIOLOGICAL:** BAT1306 and BAT8001 2.4mg/kg
- **BIOLOGICAL:** BAT1306 and BAT8001 3.6mg/kg

## Key facts

- **NCT ID:** NCT04151329
- **Lead sponsor:** Bio-Thera Solutions
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-21
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-06-30
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2019-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04151329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04151329, "A Phase I Clinical Trial of BAT1306 and BAT8001 Injection in Patients With Solid Tumor". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT04151329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*